Ascendis Pharma A (ASND) Change in Intangibles (2024 - 2026)

Ascendis Pharma A (ASND) posted Change in Intangibles of -$639305.1 for Q1 2021, up 44.03% sequentially from -$1.1 million in Q4 2020.

Analysis

Ascendis Pharma A (ASND) Change in Intangibles (2024 - 2026) Analysis & Trends

Ascendis Pharma A has reported Change in Intangibles for 2 years, with the latest figure at -$639305.1 in Q1 2021.

Quarterly Change in Intangibles changed N/A year-over-year to -$639305.1 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was -$639305.1 (changed N/A YoY) and the FY2021 annual result came in at -$606304.6, up 69.95% from the prior year.
Change in Intangibles climbed to -$639305.1 in Q1 2021 per ASND's latest filing, from -$1.1 million in the prior quarter.
Over five years, Change in Intangibles peaked at -$494096.7 in Q3 2020 and troughed at -$1.1 million in Q4 2020.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	Ascendis Pharma A	16.39 Bn	15.45 Bn	362.22 Mn	-3.76 Mn

Historic Data

Download Data